The DOI matches its Crossref record.
Cisplatin and hypomagnesemia
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Magnesium in man: implications for health and disease
de Baaij, J. H. F., Hoenderop, J. G. J., & Bindels, R. J. M. (2015) · Physiological Reviews · doi:10.1152/physrev.00012.2014 · Cited by 1,726
Cisplatin Nephrotoxicity: A Review
Yao, X., Panichpisal, K., Kurtzman, N., & Nugent, K. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31812dfe1e · Cited by 1,251
Jahnen-Dechent, W., & Ketteler, M. (2012) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfr163 · Cited by 1,054
Toxicity of platinum compounds
Hartmann, J. T., & Lipp, H.-P. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.6.889 · Cited by 604
Magnesium and Human Health: Perspectives and Research Directions
Al Alawi, A. M., Majoni, S. W., & Falhammar, H. (2018) · International Journal of Endocrinology · doi:10.1155/2018/9041694 · Cited by 472
A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity
Crona, D. J., Faso, A., Nishijima, T. F., McGraw, K. A., Galsky, M. D., & Milowsky, M. I. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0319 · Cited by 395
Gamelin, E., Gamelin, L., Bossi, L., & Quasthoff, S. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.35525 · Cited by 321
Oxaliplatin-safety profile: neurotoxicity
GROTHEY, A. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00399-3 · Cited by 319
Testicular Cancer Survivorship: Research Strategies and Recommendations
Travis, L. B., Beard, C., Allan, J. M., Dahl, A. A., Feldman, D. R., Oldenburg, J., Daugaard, G., Kelly, J. L., Dolan, M. E., Hannigan, R., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq216 · Cited by 294
Self-citation
Metadata
- Authors
- Lajer, H., & Daugaard, G.
- Venue
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Published
- 1999-02
- Volume
- 25
- Issue
- 1
- Pages
- 47-58
- ISSN
- 0305-7372 (ISSN-L)
- OpenAlex
- W2089603028
- Cited by
- 250
- References
- 0
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.